Microbial Products Market Size, Share, and Trends 2026 to 2035

Revenue, 2025

USD 220.79 Bn

Forecast Year, 2035

USD 368.51 Bn

CAGR, 2026 - 2035

5.26%

Report Coverage

Global

What is the Microbial Products Market Size?

The global microbial products market size is calculated at USD 220.79 billion in 2025 and is predicted to increase from USD 232.49 billion in 2026 to approximately USD 368.51 billion by 2035, expanding at a CAGR of 5.26% from 2026 to 2035.

Microbial Products Market Key Takeaways

• North America dominated microbial products market in 2025.
• By source, the bacterial segment dominated the market in 2025.
• By application, the biotechnology segment led the market in 2025.

Market Overview

The primary producers of beneficial natural compounds are microbes. Natural substances produced by microorganisms and plants make great medicines. The creation of these beneficial secondary metabolites takes up a sizable percentage of microbial genomes. Moreover, anticoagulants, antidepressants, herbicides, vasodilators, plant hormones, insecticides, vitamins and enzymes are only a few examples of the medications that have been extracted from microbes or manufactured in vast numbers by genetically engineering the organisms with other genes. Moreover, it has a significance importance in the field of pharmaceuticals and healthcare sector owning to its beneficial attributes.

Many foods, including bread, cheese, and sauerkraut, including some that are nearly totally made of microbes themselves, like yeast extract or mycoprotein meat substitutes, are produced by microbes. Microbes can, however, also significantly change the flavors of food. The distinctive metabolites that each bacterium creates will vary depending on the nutrients that are accessible to them. Other microbes may then convert them into still more compounds, thus it's critical to have the ideal microbial balance in order to achieve the desired flavors. In the manufacturing of industrial food, starting cultures are frequently used to introduce a balance of desired bacteria and guarantee consistency in the end product.

Microbial Products Market Growth Factors

The rising demands for diagnostic microbiological products as well as the expanding necessity for healthcare nutrients like vitamins are driving the microbial products in the market. In addition, the sector is anticipated to grow in the coming years because to the rising prevalence of diseases like cancer. The global market for microbial products is also being boosted by the expanding use of microbial products in the production of medicinal and agricultural goods using genetic engineering techniques. Recent developments in fermentation technology have provided a consistent, significant boost to the market's growth.

Moreover, regardless of whether individuals are living in underdeveloped or industrialized countries, microbial healthcare products have now greatly expanded their use in primary and secondary human healthcare systems. In the primary healthcare system, microbial products can be used for immunization, the treatment of common illnesses, the prevention of locally endemic diseases, and other purposes. However, secondary healthcare systems are fully justified in using them for chemotherapy and more organized hospital treatment of complicated infectious diseases. Numerous items with microbial origin are marketed by the vast majority of multinational corporations, who profit greatly from these products.

Industry operators are now able to make more economical and environmentally friendly products because to the development of genetic recombinant technology. The market is expanding because to the increasing importance of microbial products in the manufacturing of enzymes for end-use industries like paper, leather, and food preservation.

It has various applications including aiding in the production of biogas. A combination of gases is produced by microbial action, mostly methane. The fuel in consideration is biogas. Depending on the substrates they consume, different bacteria produce various gases. Anaerobic bacteria produce a lot of methane, coupled with CO2 and H2, as they consume cellulose. Methanogens are these bacteria. Because these bacteria aid in the breakdown of cellulose in cattle rumens, cattle dung is likewise abundant in them. Consequently, biogas is frequently produced using animal faeces. Due to the abundance of livestock dung in communities, biogas plants are more prevalent in rural regions.

These factors are influencing the demand of microbial products in the market across the globe, and it is expected that market will grow with a consistent rate. The benefits associated with these products are advantage that makes it a unique product from different alternatives in the market.

Market Scope

Segment Insights

[[segment_insights]]

Regional Insights

[[regional_insights]]

Microbial Products Market Companies

• Merck & Co. Inc.
• Valent BioSciences Corp.
• Genomatica
• Genzyme Corp
• AB Mauri
• Amyris Inc.
• Pfizer Inc., Ltd
• Sanofi S.A
• Novartis AG
• Biomérieux SA
• Ajinomoto Co. Inc.
• CertisUsa
• Durect Corp.
• Earthrise NutritionalsLlc
• Energy Derived
• Environmental Biotechnologies Inc.

Key market developments

• In 2017, the world's top provider of food safety testing, BioControl Systems Inc., was bought by Merck, a renowned life science and technology business. The acquisition presents Merck with growth potential, particularly in the U.S., in the food and beverage sector.

Segments covered in the report

[[segment_covered]]